Client News

Imcyse SA: Imcyse Announces Start of Phase 1b/2a IMPACT Study in Patients with Recent Onset Type 1 Diabetes

XPhyto announces psychedelic pharmaceutical production agreement

CENTOGENE GmbH: CENTOGENE eröffnet Walk-In-Corona-Testzentrum am Flughafen Köln / Bonn

CEVEC and CARISMA Therapeutics sign license agreement for the use of CAP® Technology in anti-tumor cell therapies

CureVac and Rentschler Biopharma Ramp up Manufacturing of COVID-19 Vaccine, CVnCoV

AiCuris changes its legal form: AiCuris Anti-infective Cures GmbH becomes AiCuris AG

RedHill Biopharma Announces Positive DSMB Futility Review for Phase 2/3 COVID-19 Study of Opaganib

Marinomed Biotech AG announces preliminary revenues and confirms outlook for 2020

RedHill Biopharma Further Expands Opaganib Manufacturing Capacity for COVID-19 with Cosmo Pharmaceuticals

XPhyto announces drug formulation strategy and 2021 milestones